Global Health - Reproductive and Child Health
The foundation awarded 70 grants totaling $1,219,857,173 to improve health in the developing world. Of that amount, 48 grants, totaling $214,097,156, were directed toward Reproductive and Child Health.
11/22/99
Help the Afghan Children, Inc.
Integrated Community-based Primary and Maternal/Child Health Care Services in Southwestern Afghanistan
Vienna, VA
$1,600,000 (over 2 years)
A grant to maintain the primary and maternal/child health care services provided by Afghan Health and Development Services in southwestern Afghanistan.
11/22/99
International Planned Parenthood Federation
Family Planning Association of India - Small Family by Choice
England
$1,629,282 (over 2 years)
A grant for the continuation of the Small Family by Choice project in three districts in the State of Madhya Pradesh, India. The project, started in 1994, takes a holistic approach to reproductive health that includes family planning as well as safe motherhood, child survival, women's empowerment, and other activities.
11/22/99
Public Health Institute
Family Planning Leadership Development Program
Berkeley, CA
$2,998,669 (over 3 years)
A grant in support of the Family Planning Leadership Development Program based at the International Health Program in Santa Cruz, California. The program will train an influential cadre of family planning leaders from developing countries over the next three years.
11/22/99
DKT Ethiopia
Saving Lives through Social Marketing in Ethiopia
Ethiopia
$4,302,367 (over 4 years)
A four-year grant to reduce infant mortality and HIV transmission among adolescents through the expansion of DKT's social marketing programs.
11/22/99
Center for Development in Population Activities (CEDPA)
Supporting Women's Leadership in Population and Development
Washington, DC
$5,000,000 (over 5 years)
This five-year project will enable CEDPA to initiate a program to provide leadership skills and tools to women in local non governmental organizations. Innovative approaches to individual and institutional capacity building will be targeted to expand and improve programs for reproductive and child health and women's economic development.
11/22/99
University of California, Berkeley
Bay Area International Group
Berkeley, CA
$645,000 (over 3 years)
Operational support for the Bay Area International Group (BIG) which was formed in 1997 to take a hard empirical look at international family planning and reproductive health programs in order to help policy makers make the best use of limited resources.
9/27/99
National Institute of Child Health and Human Development
Global Network for Maternal and Child Health, Population and Human Development
Bethesda, MD
$15,000,000 (over 5 years)
A grant in support of a global network involving several NIH Institutes in an effort to expand global research and health intervention capacity, and to encourage leading U.S. scientists to address women and children's disease prevention and treatment issues critically important to the developing world.
9/23/99
University of Michigan School of Public Health
Participatory On-Site Training Backed by an Electronic Communications Network
Ann Arbor, MI
$5,000,000 (over 5 years)
A collaborative program between the University of Michigan, the Population Council of Brazil, and REPROLATINA designed to bring about major change in the availability and quality of family planning services for poor populations in Latin America.
8/30/99
Alliance for Cervical Cancer
Alliance for Cervical Cancer
United States
$32,645,842 (over 3 years)
Part of an overall $50 million, five-year commitment supporting an alliance of five agencies to work collaboratively on preventing cervical cancer in developing countries.
8/19/99
Population Council
Making Microbicides a Reality
New York, NY
$4,000,000 (over 2 years)
To develop, test and bring to the market a vaginal microbicide product for women. The Council's lead compound, PC-515, composed primarily of the seaweed derivative carrageenan, has proved most efficacious in blocking viral infection. PC-515 will be the first non-contraceptive microbicide to move into larger scale human testing.
Page 1 of 5
Next 10 >